From new hires to departures, promotions, and transfers, here are the latest comings and goings in the pharmaceutical industry.
“How do we make sure that a technology like CRISPR — you know, no offense intended — is not just going to make a few people rich, but it’s going… […]
STAT+: Gilead and Teva defend antitrust claims that prices for HIV medicines were unfairly kept high
“We’ve lost an opportunity to have direct government purchases of hundreds of thousands of doses of generic Truvada at a lower cost to dramatically lower HIV infections,” said Peter Staley… […]
A new Bay Area biotech is harnessing artificial intelligence to better understand and predict RNA structures in hopes of developing new therapeutics. […]